CALGARY, AB, May 9, 2025 /PRNewswire/ - Enbridge Inc. (Enbridge or the Company) (TSX: ENB) (NYSE: ENB) today reported first quarter 2025 financial results, reaffirmed its 2025 financial guidance and provided a quarterly business update. Highlights (All financial figures are unaudited and in Canadian …
ONEX Corporation Allamountsin U.S.dollars unlessotherwisestated TORONTO, May 09, 2025 (GLOBE NEWSWIRE) -- Onex Corporation (TSX: ONEX) today announced its financial results for the first quarter ended March 31, 2025. “Onex continues to make progress and is benefitting from recent operational enhancements and a focus …
(Bloomberg) -- Major tech companies lobbying to salvage a tax deduction for research and development are warning they may pull back from high-profile pledges of new US investments if Congress doesn’t fully reinstate the break. Most Read from Bloomberg Is Trump’s Plan to Reopen …
Patients lived significantly longer without high-risk disease recurrence or progression after one year of IMFINZI treatment plus Bacillus Calmette-Guérin (BCG) induction and maintenance therapy vs. BCG alone WILMINGTON, Del., May 09, 2025--(BUSINESS WIRE)--Positive high-level results from the POTOMAC Phase III trial showed one year …
Known for his philosophy of INVESTING IN WHAT YOU KNOW, Peter Lynch looked for companies with CONSISTENT EARNINGS GROWTH, LOW DEBT, AND A COMPETITIVE EDGE. Does DONNELLEY FINANCIAL SOLUTION (NYSE:DFIN[https://www.chartmill.com/stock/quote/DFIN/profile]) meet these key criteria? Let’s find out. [Growth stocks image] FOLLOWING PETER LYNCH’S APPROACH: …
Kymera Therapeutics, Inc. Completed KT-621 (STAT6) SAD/MAD Phase 1 healthy volunteer trial with data to be reported in June 2025 First patient dosed in KT-621 (STAT6) BroADen Phase 1b trial in moderate to severe atopic dermatitis (AD) with data expected in 4Q25 KT-579 (IRF5) …
MIAMI, May 09, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Prime carotid stent system for the treatment of carotid artery disease and prevention of stroke, today announced financial and operating results for the first quarter ended March 31, 2025. …
Reports first quarter 2025 total revenue of $7.2 million, representing 28% growth compared to the first quarter of 2024. Reports record quarterly service revenue led by strong validation activity. Reports first quarter gross margin of 6%, representing a 33-percentage point improvement compared to the …
- Outstanding Business Volume of $29.8 Billion - WASHINGTON, May 9, 2025 /PRNewswire/ -- The Federal Agricultural Mortgage Corporation (Farmer Mac; NYSE: AGM and AGM.A), the nation's secondary market provider that increases the accessibility of financing to provide vital liquidity for American agriculture and …
DENVER, May 09, 2025--(BUSINESS WIRE)--BKV Corporation (NYSE: BKV) ("BKV" or the "Company"), today reported financial and operational results for the first quarter of 2025, including guidance for the second quarter of 2025. First Quarter and Subsequent Highlights Announced a joint venture agreement with Copenhagen …